What is the share price of Anuh Pharma Ltd (ANUHPHR) today?
The share price of ANUHPHR as on 5th December 2025 is ₹79.78. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Anuh Pharma Ltd (ANUHPHR) share?
The past returns of Anuh Pharma Ltd (ANUHPHR) share are- Past 1 week: 2.61%
- Past 1 month: -11.05%
- Past 3 months: -7.18%
- Past 6 months: -26.93%
- Past 1 year: -28.84%
- Past 3 years: N/A%
- Past 5 years: -28.84%
What are the peers or stocks similar to Anuh Pharma Ltd (ANUHPHR)?
The peers or stocks similar to Anuh Pharma Ltd (ANUHPHR) include:What is the dividend yield % of Anuh Pharma Ltd (ANUHPHR) share?
The current dividend yield of Anuh Pharma Ltd (ANUHPHR) is 0.95.What is the market cap of Anuh Pharma Ltd (ANUHPHR) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Anuh Pharma Ltd (ANUHPHR) is ₹794.68 Cr as of 5th December 2025.What is the 52 week high and low of Anuh Pharma Ltd (ANUHPHR) share?
The 52-week high of Anuh Pharma Ltd (ANUHPHR) is ₹122.85 and the 52-week low is ₹74.25.What is the PE and PB ratio of Anuh Pharma Ltd (ANUHPHR) stock?
The P/E (price-to-earnings) ratio of Anuh Pharma Ltd (ANUHPHR) is 16.78. The P/B (price-to-book) ratio is 2.44.Which sector does Anuh Pharma Ltd (ANUHPHR) belong to?
Anuh Pharma Ltd (ANUHPHR) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Anuh Pharma Ltd (ANUHPHR) shares?
You can directly buy Anuh Pharma Ltd (ANUHPHR) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Anuh Pharma Ltd
ANUHPHR Share Price
79.780.62% (+0.49)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
ANUHPHR Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
ANUHPHR Performance & Key Metrics
ANUHPHR Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 20.53 | 2.44 | 0.95% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.94 | 5.83 | 0.58% |
ANUHPHR Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
ANUHPHR Company Profile
Anuh Pharma Ltd specializes in manufacturing and selling active pharmaceutical ingredients and corticosteroids for various therapeutic applications.
SUNPHARMA
PE Ratio
39.92
39.92
1Y Return
1.01%
1.01%
Buy Reco %
91.67
91.67
TORNTPHARM
PE Ratio
67.21
67.21
1Y Return
13.21%
13.21%
Buy Reco %
76.92
76.92
CIPLA
PE Ratio
23.30
23.30
1Y Return
1.34%
1.34%
Buy Reco %
70.00
70.00
DRREDDY
PE Ratio
18.81
18.81
1Y Return
5.10%
5.10%
Buy Reco %
41.94
41.94
LUPIN
PE Ratio
29.12
29.12
1Y Return
0.46%
0.46%
Buy Reco %
72.22
72.22
ANUHPHR Forecast
ANUHPHR Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
ANUHPHR
ANUHPHR
Income
Balance Sheet
Cash Flow
Annual Normal View
ANUHPHR Income Statement
ANUHPHR Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 213.73 | 245.47 | 325.36 | 311.17 | 442.50 | 491.85 | 533.60 | 659.10 | 670.97 | 736.72 | ||||||||||
Raw Materials | 148.76 | 184.07 | 249.16 | 243.67 | 327.49 | 382.54 | 388.00 | 501.90 | 501.82 | 674.38 | ||||||||||
| Power & Fuel Cost | 3.07 | 4.09 | 4.79 | 6.31 | 8.66 | 8.80 | 11.02 | 12.37 | 12.35 | |||||||||||
| Employee Cost | 7.22 | 8.90 | 10.14 | 13.36 | 14.29 | 15.10 | 17.15 | 19.39 | 23.04 | |||||||||||
| Selling & Administrative Expenses | 7.45 | 8.53 | 9.98 | 8.90 | 11.17 | 12.07 | 13.28 | 15.50 | 17.76 | |||||||||||
| Operating & Other expenses | 16.96 | 14.18 | 16.63 | 11.48 | 25.23 | 20.67 | 46.23 | 22.09 | 45.01 | |||||||||||
EBITDA | 30.27 | 25.70 | 34.66 | 27.45 | 55.66 | 52.67 | 57.92 | 87.85 | 70.99 | 62.34 | ||||||||||
| Depreciation/Amortization | 1.97 | 1.83 | 1.66 | 7.03 | 15.08 | 11.96 | 9.70 | 8.58 | 8.74 | 10.32 | ||||||||||
| PBIT | 28.30 | 23.87 | 33.00 | 20.42 | 40.58 | 40.71 | 48.22 | 79.27 | 62.25 | 52.02 | ||||||||||
| Interest & Other Items | 0.72 | 0.45 | 0.60 | 1.26 | 2.03 | 1.58 | 0.75 | 0.96 | 1.24 | 0.60 | ||||||||||
| PBT | 27.58 | 23.42 | 32.40 | 19.16 | 38.55 | 39.13 | 47.47 | 78.31 | 61.01 | 51.42 | ||||||||||
| Taxes & Other Items | 7.54 | 6.90 | 9.04 | 4.85 | 10.12 | 8.56 | 11.29 | 18.25 | 13.65 | 12.71 | ||||||||||
| Net Income | 20.04 | 16.52 | 23.36 | 14.31 | 28.43 | 30.57 | 36.18 | 60.06 | 47.36 | 38.71 | ||||||||||
| EPS | 1.00 | 0.82 | 1.17 | 0.71 | 1.42 | 1.53 | 1.80 | 3.00 | 3.15 | 3.86 | ||||||||||
| DPS | 0.63 | 0.69 | 0.69 | 0.69 | 0.75 | 0.88 | 1.00 | 1.25 | 0.75 | 1.50 | ||||||||||
| Payout ratio | 0.63 | 0.83 | 0.59 | 0.96 | 0.53 | 0.57 | 0.55 | 0.42 | 0.24 | 0.39 |
ANUHPHR Company Updates
FY 2026FY 2026
Investor Presentation
Nov 17PDF
Aug 22PDF
ANUHPHR Stock Peers
ANUHPHR Past Performance & Peer Comparison
ANUHPHR Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Anuh Pharma Ltd | 16.78 | 2.44 | 0.95% |
| Sun Pharmaceutical Industries Ltd | 39.92 | 6.02 | 0.88% |
| Torrent Pharmaceuticals Ltd | 67.21 | 16.92 | 0.84% |
| Cipla Ltd | 23.30 | 3.93 | 1.05% |
ANUHPHR Stock Price Comparison
Compare ANUHPHR with any stock or ETFCompare ANUHPHR with any stock or ETF
ANUHPHR
ANUHPHR Holdings
ANUHPHR Shareholdings
ANUHPHR Promoter Holdings Trend
ANUHPHR Promoter Holdings Trend
Increased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has increased by 1.90%
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
ANUHPHR Institutional Holdings Trend
ANUHPHR Institutional Holdings Trend
Decreased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has decreased by 2.20%
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
ANUHPHR Shareholding Pattern
ANUHPHR Shareholding Pattern
ANUHPHR Shareholding History
ANUHPHR Shareholding History
Foreign Institutions
Mutual Funds Invested in ANUHPHR
Mutual Funds Invested in ANUHPHR
No mutual funds holding trends are available
Top 1 Mutual Funds holding Anuh Pharma Ltd
| Funds (Top 1) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0005% | Percentage of the fund’s portfolio invested in the stock 0.02% | Change in the portfolio weight of the stock over the last 3 months 0.02% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 118/124 (-4) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing ANUHPHR stock
smallcases containing ANUHPHR stock
Looks like this stock is not in any smallcase yet.
ANUHPHR Events
ANUHPHR Events
ANUHPHR Dividend Trend
No Trend In Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
ANUHPHR has shown inconsistent dividend trend over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 0.95%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹9.46 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
ANUHPHR Dividend Trend
No Trend In Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
ANUHPHR has shown inconsistent dividend trend over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 0.95%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹9.46 every year
ANUHPHR Upcoming Dividends
ANUHPHR Upcoming Dividends
No upcoming dividends are available
ANUHPHR Past Dividends
ANUHPHR Past Dividends
Cash Dividend
Ex DateEx DateAug 14, 2025
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Aug 14, 2025
Cash Dividend
Ex DateEx DateAug 16, 2024
Final
Final | Div/Share: ₹2.50
Dividend/Share
₹2.50
Ex DateEx Date
Aug 16, 2024
Cash Dividend
Ex DateEx DateAug 11, 2023
Final
Final | Div/Share: ₹2.00
Dividend/Share
₹2.00
Ex DateEx Date
Aug 11, 2023
Cash Dividend
Ex DateEx DateAug 3, 2022
Final
Final | Div/Share: ₹1.75
Dividend/Share
₹1.75
Ex DateEx Date
Aug 3, 2022
Cash Dividend
Ex DateEx DateAug 17, 2021
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Aug 17, 2021
ANUHPHR Stock News & Opinions
ANUHPHR Stock News & Opinions
Articles & Videos
Earnings
Anuh Pharma standalone net profit declines 49.40% in the September 2025 quarter
Net profit of Anuh Pharma declined 49.40% to Rs 7.61 crore in the quarter ended September 2025 as against Rs 15.04 crore during the previous quarter ended September 2024. Sales rose 12.01% to Rs 185.88 crore in the quarter ended September 2025 as against Rs 165.95 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales185.88165.95 12 OPM %6.3910.17 - PBDT12.7820.11 -36 PBT9.9218.19 -45 NP7.6115.04 -49 Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Corporate
Anuh Pharma to announce Quarterly Result
Anuh Pharma will hold a meeting of the Board of Directors of the Company on 7 November 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Anuh Pharma standalone net profit declines 12.72% in the June 2025 quarter
Net profit of Anuh Pharma declined 12.72% to Rs 8.30 crore in the quarter ended June 2025 as against Rs 9.51 crore during the previous quarter ended June 2024. Sales rose 35.22% to Rs 186.48 crore in the quarter ended June 2025 as against Rs 137.91 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales186.48137.91 35 OPM %5.527.66 - PBDT13.4714.15 -5 PBT10.9512.27 -11 NP8.309.51 -13 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Anuh Pharma to discuss results
Anuh Pharma will hold a meeting of the Board of Directors of the Company on 8 August 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Anuh Pharma revises record date for final dividend
Anuh Pharma announced that the revised record date for payment of final dividend for FY 2024-25 is 15 August 2025. Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Board of Anuh Pharma allots 5.01 lakh bonus equity shares
The Board of Anuh Pharma at its meeting held on 16 July 2025 has allotted 5,01,12,000 fully paid up equity shares of face value of Rs 5 each in ratio of 1:1. Consequently, the paid up equity share capital has increased to 10,02,24,000 equity shares of Rs 5 each aggregating to Rs 50,11,20,000/-.Powered by Capital Market - Live
4 months agoCapital Market - Live
Spotlight
Anuh Pharma gains after inaugurating new manufacturing block in Maharashtra
In a regulatory filing, the company stated that the new facility is expected to become operational within July 2025. Upon commencement, the plant will expand Anuh Pharma's manufacturing capacity by an additional 200 metric tons per annum (MT/Annum). Post-expansion, the company's total production capacity will increase from approximately 2,200 MT/Annum to 2,400 MT/Annum. The newly inaugurated INT-1A block is also equipped with an additional 40 kiloliters (KL) of reactor capacity, enhancing the company's infrastructure and positioning it to meet growing market demand more effectively. Anuh Pharma, a bulk drug manufacturing company, is part of the Rs 8.5 bn SK Group of Companies, which employs 2000+ people across businesses such as manufacturing of APIs, pharma formulations, distribution, and logistics. Established in 1960, Anuh Pharma today is one of the largest manufacturers of macrolides and anti-TB products in India, besides being a major player in anti-bacterials, anti-malarials, and corticosteroids. The company's standalone net profit fell 18.9% to Rs 12.46 crore, while revenue from operations jumped 20.9% to Rs 198.14 crore in Q4 March 2025 over Q4 March 2024. Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Anuh Pharma fixes record date for bonus issue
Anuh Pharma has fixed 15 July 2025 as record date for issuance of bonus shares in ratio of 1:1. Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Anuh Pharma schedules AGM
Anuh Pharma announced that the 65th Annual General Meeting(AGM) of the company will be held on 22 August 2025.Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Board of Anuh Pharma recommends final dividend
Anuh Pharma announced that the Board of Directors of the Company at its meeting held on 23 May 2025, inter alia, have recommended the final dividend of Rs 1.5 per equity Share (i.e. 30%) , subject to the approval of the shareholders.Powered by Capital Market - Live
6 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 16.61%, vs industry avg of 10.03%
Over the last 5 years, market share increased from 0.12% to 0.16%
Over the last 5 years, net income has grown at a yearly rate of 27.04%, vs industry avg of 20.02%